P. Arends

1.1k total citations
15 papers, 601 citations indexed

About

P. Arends is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, P. Arends has authored 15 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 13 papers in Hepatology and 2 papers in Surgery. Recurrent topics in P. Arends's work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). P. Arends is often cited by papers focused on Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (13 papers) and Liver Disease Diagnosis and Treatment (9 papers). P. Arends collaborates with scholars based in Netherlands, Canada and Italy. P. Arends's co-authors include Harry L.A. Janssen, Bettina E. Hansen, Johan F. Lange, Wim C.J. Hop, Gabriëlle H. van Ramshorst, J. Nieuwenhuizen, Johannes Jeekel, Robert J. de Knegt, Heng Chi and Milan J. Sonneveld and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

P. Arends

15 papers receiving 577 citations

Peers

Countries citing papers authored by P. Arends

Since Specialization

Citations

This map shows the geographic impact of P. Arends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Arends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Arends more than expected).

Fields of papers citing papers by P. Arends

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Arends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Arends. The network helps show where P. Arends may publish in the future.

Co-authorship network of co-authors of P. Arends

This figure shows the co-authorship network connecting the top 25 collaborators of P. Arends. A scholar is included among the top collaborators of P. Arends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Arends. P. Arends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Pegylated Interferon Alfa-2b Add-on Treatment in Hepatitis B Virus Envelope Antigen-Positive Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogue: A Randomized, Controlled Trial (PEGON) 2017 ·The Journal of Infectious Diseases ·Heng Chi, Bettina E. Hansen, Simin Guo, (unknown), Xun Qi, Liang Chen, Qing Guo, P. Arends, Jiyao Wang, Elke Verhey, Robert J. de Knegt, Qing Xie, Harry L.A. Janssen	36
2	Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up 2016 ·Clinical Gastroenterology and Hepatology ·Willem Pieter Brouwer, Henry Lik‐Yuen Chan, Maurizia Rossana Brunetto, Michelle Martinot-Peignoux, P. Arends, Markus Cornberg, B. Cherubini, A. Thompson, Yun‐Fan Liaw, Patrick Marcellin, Harry L.A. Janssen, Bettina E. Hansen	47
3	Reduced risk of relapse after long‐term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B 2015 ·Alimentary Pharmacology & Therapeutics ·Heng Chi, Bettina E. Hansen, (unknown), P. Arends, Mahmoud Abu‐Amara, Annemiek A. van der Eijk, Jordan J. Feld, Robert J. de Knegt, David Wong, Harry L.A. Janssen	80
4	Real life adherence of chronic hepatitis B patients to entecavir treatment 2015 ·Digestive and Liver Disease ·(unknown), P. Arends, (unknown), Joop E. Arends, Willem Pieter Brouwer, Peter D. Siersema, Harry L.A. Janssen, Karel J. van Erpecum	23
5	P0661 : Prediction of HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients treated with entecavir using ALT and platelet count: Results from a large european multi-center study 2015 ·Journal of Hepatology ·Heng Chi, Florian van Bömmel, Marı́a Buti, Ashley Brown, Ivana Carey, M. Fasano, David Mutimer, Katja Deterding, Ye Htun Oo, P. Arends, Robert J. de Knegt, Teresa Santantonio, Tania M. Welzel, Pierre Pradat, J. Petersen, Heiner Wedemeyer, Thomas Berg, Fabien Zoulim, Bettina E. Hansen, Harry L.A. Janssen	5
6	Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir 2014 ·Journal of Hepatology ·George Papatheodoridis, George Ν. Dalekos, Cihan Yurdaydın, Marı́a Buti, John Goulis, P. Arends, Vana Sypsa, Spilios Manolakopoulos, Giampaolo Mangia, Nikolaos Gatselis, Onur Keskın, Savvoula Savvidou, Bettina E. Hansen, Christos Papaioannou, (unknown), Ramazan Idılman, Massimo Colombo, Rafael Esteban, Harry L.A. Janssen, Pietro Lampertico	118
7	P1075 PAGE-B: RISK SCORE FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS RECEIVING ENTECAVIR (ETV) OR TENOFOVIR (TDF) 2014 ·Journal of Hepatology ·George Papatheodoridis, George Ν. Dalekos, Vana Sypsa, Cihan Yurdaydın, Marı́a Buti, John Goulis, P. Arends, Spilios Manolakopoulos, (unknown), Nikolaos Gatselis, Onur Keskın, Savvoula Savvidou, Bettina E. Hansen, Christos Papaioannou, (unknown), Ramazan Idılman, Massimo Colombo, Rafael Esteban, (unknown), Pietro Lampertico	9
8	P1077 HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B 2014 ·Journal of Hepatology ·Heng Chi, P. Arends, David Wong, (unknown), Bettina E. Hansen, (unknown)	1
9	Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline 2014 ·Journal of Viral Hepatitis ·P. Arends, Vincent Rijckborst, Pieter E. Zondervan, Erik H.C.J. Buster, Yılmaz Çakaloğlu, Péter Ferenci, Fehmı Tabak, Ulus Salih Akarca, Krzysztof Simon, Milan J. Sonneveld, Bettina E. Hansen, Harry L.A. Janssen	6
10	Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B 2013 ·Journal of Hepatology ·Milan J. Sonneveld, P. Arends, André Boonstra, Bettina E. Hansen, Harry L.A. Janssen	43
11	Hepatitis B virus treatment: Which patients should be treated with interferon? 2013 ·Clinical Liver Disease ·P. Arends, Milan J. Sonneveld, Harry L.A. Janssen	3
12	737 POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS 2013 ·Journal of Hepatology ·Willem Pieter Brouwer, P. Arends, Vincent Rijckborst, Martijn J. ter Borg, Yılmaz Çakaloğlu, Péter Ferenci, Fehmı Tabak, Meral Akdoğan, Krzysztof Simon, M. Raptopoulou‐Gigi, Necati Örmecı, Ulus Salih Akarca, Robert Flisiak, Bettina E. Hansen, André Boonstra, (unknown)	4
13	Presence of Anti-Interferon Antibodies is Not Associated with Non-Response to Pegylated Interferon Treatment in Chronic Hepatitis B 2013 ·Antiviral Therapy ·P. Arends, Annemiek A. van der Eijk, Milan J. Sonneveld, Bettina E. Hansen, Harry L.A. Janssen, Bart L. Haagmans	3
14	Abdominal Wound Dehiscence in Adults: Development and Validation of a Risk Model 2009 ·World Journal of Surgery ·Gabriëlle H. van Ramshorst, J. Nieuwenhuizen, Wim C.J. Hop, P. Arends, (unknown), Johannes Jeekel, Johan F. Lange	212
15	DDAVP-Induced Changes of Factor VIII-Related Activities and Bleeding Time in Patients with von Willebrand’s Syndrome 1980 ·Pathophysiology of Haemostasis and Thrombosis ·(unknown), (unknown), P. Arends, (unknown), (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact